Obinutuzumab in Combination With GDP Chemotherapy in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma
University Health Network, Toronto
University Health Network, Toronto
University of Nebraska
Eli Lilly and Company
Eli Lilly and Company
Canadian Cancer Trials Group
University of Maryland, Baltimore
M.D. Anderson Cancer Center
Montefiore Medical Center
Weill Medical College of Cornell University
Alliance for Clinical Trials in Oncology
SWOG Cancer Research Network
National Cancer Institute (NCI)
Scripps Health
Temple University
Royal Marsden NHS Foundation Trust
Eli Lilly and Company